Vericel

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vericel and other ETFs, options, and stocks.

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel.

CEO

Dominick C. Colangelo

CEODominick C. Colangelo

Employees

398

Employees398

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1989

Founded1989

Employees

398

Employees398

VCEL Key Statistics

Market cap

1.71B

Market cap1.71B

Price-Earnings ratio

107.36

Price-Earnings ratio107.36

Dividend yield

—

Dividend yield—

Average volume

517.52K

Average volume517.52K

High today

$33.79

High today$33.79

Low today

$33.00

Low today$33.00

Open price

$33.21

Open price$33.21

Volume

408.47K

Volume408.47K

52 Week high

$50.36

52 Week high$50.36

52 Week low

$29.24

52 Week low$29.24

Stock Snapshot

Vericel(VCEL) stock is priced at $33.71, giving the company a market capitalization of 1.71B. It carries a P/E multiple of 107.36.

During the trading session on 2026-03-06, Vericel(VCEL) shares reached a daily high of $33.79 and a low of $33.00. At a current price of $33.71, the stock is +2.2% higher than the low and still -0.2% under the high.

Trading activity shows a volume of 408.47K, compared to an average daily volume of 517.52K.

Over the past 52 weeks, Vericel(VCEL) stock has traded between a high of $50.36 and a low of $29.24.

VCEL News

Simply Wall St 16h

Vericel Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed?

Vericel Corporation recently received U.S. Food and Drug Administration approval to begin commercial manufacturing of its MACI cartilage repair therapy at a new...

Nasdaq 2d

Vericel Wins FDA Approval For New Advanced Therapy Manufacturing Facility - Nasdaq

...

TipRanks 3d

Vericel announces U.S. FDA approval of new manufacturing facility

Vericel (VCEL) Corporation announced that the U.S. Food and Drug Administration, FDA, has granted approval for MACI commercial manufacturing at its state-of-the...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

More VCEL News

TipRanks 6d

Vericel Earnings Call Highlights MACI-Fueled Growth

Vericel Corporation ((VCEL)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level...

Simply Wall St 7d

A Look At Vericel Valuation After Record Q4 Results And 2026 Growth Guidance

Vericel (VCEL) just paired record fourth quarter results with fresh 2026 guidance. This puts its MACI franchise, expanding sales force, and new manufacturing pl...

People also own

Based on the portfolios of people who own VCEL. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.